The Converge platform validated as many as 83% of its treatment targets in disease models, a higher success rate than usual ...

Ractigen's RAG-21, a treatment for ALS linked to mutations in the FUS gene, has been granted orphan drug designation in the U ...

The world's largest ALS patient-derived stem cell and biodata repository is now available to researchers globally.

A grant from the ALS Association will fund an early-stage clinical trial to test Tiziana's foralumab nasal spray in 20 ALS ...

Although she did everything possible to learn about ALS, columnist Juliet Taylor says the disease often left her feeling ...

A newly awarded grant from the ALS Association will support Asha Therapeutics' work to advance ASHA-624 into a first-in-human ...

Lately columnist Dagmar Munn has been feeling unmotivated and exhausted, but she has several strategies that help her get out ...

A Phase 2 trial testing oral ROCK inhibitor Bravyl in people with ALS is now fully enrolled at its highest dosing group.

The newly combined company will focus on moving Kadimastem's AstroRx, NLS's DOXA platform, and other therapies through ...

The EMA recommended that NUZ-001, formerly monepantel, be granted orphan medicinal product designation to treat ALS in Europe ...

The National Institute of Aging awarded a $7.3 million research grant for the study of NU-9 as a treatment for ...

Trace Neuroscience has launched in the U.S. with over $100 million in financing and a goal to develop its UNC13A-targeted ...